ACHC - Acadia Healthcare Company, Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Franklin,
United States
Type: Equity
ACHC price evolution
ACHC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $77.17 | $77.3 | $100.07 | |
| Short term investments | ||||
| Net receivables | $489.18 | $389.37 | $386.19 | $361.45 |
| Inventory | $5.51 | $5.99 | $5.75 | $5.3 |
| Total current assets | $652.06 | $645.21 | $610.81 | $596 |
| Long term investments | ||||
| Property, plant & equipment | $2802.58 | $2621.13 | $2497.41 | $2384.39 |
| Goodwill & intangible assets | $2334.74 | $2334.38 | $2299.24 | |
| Total noncurrent assets | $5032.84 | $4906.44 | $4762.84 | |
| Total investments | ||||
| Total assets | $5870.46 | $5678.05 | $5517.25 | $5358.84 |
| Current liabilities | ||||
| Accounts payable | $201.38 | $159.52 | $156.13 | $156.13 |
| Deferred revenue | ||||
| Short long term debt | $93.58 | $88.27 | $55.49 | |
| Total current liabilities | $609.5 | $546.52 | $482.31 | $885.78 |
| Long term debt | $1804.83 | $1879.26 | $1897.65 | $1443.36 |
| Total noncurrent liabilities | $2066.93 | $2059.58 | $1585.4 | |
| Total debt | $1972.85 | $1985.91 | $1498.84 | |
| Total liabilities | $2838.94 | $2613.46 | $2541.89 | $2471.18 |
| Shareholders' equity | ||||
| Retained earnings | $354.72 | $286.59 | $208.1 | $131.72 |
| Other shareholder equity | ||||
| Total shareholder equity | $2952.72 | $2866.02 | $2781.97 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $100.07 | $97.65 | $133.81 | $378.7 |
| Short term investments | ||||
| Net receivables | $361.45 | $343.58 | $281.33 | $273.55 |
| Inventory | $5.3 | $5.09 | $4.79 | $4.9 |
| Total current assets | $596 | $506.13 | $495.03 | $2523.39 |
| Long term investments | ||||
| Property, plant & equipment | $2384.39 | $2087.28 | $1904.92 | $1719.83 |
| Goodwill & intangible assets | $2299.24 | $2298.85 | $2270.08 | $2173.8 |
| Total noncurrent assets | $4762.84 | $4481.78 | $4273.05 | $3975.97 |
| Total investments | ||||
| Total assets | $5358.84 | $4987.9 | $4768.08 | $6499.36 |
| Current liabilities | ||||
| Accounts payable | $156.13 | $104.72 | $98.58 | $87.81 |
| Deferred revenue | ||||
| Short long term debt | $55.49 | $47.71 | $41.94 | $172.39 |
| Total current liabilities | $885.78 | $388.33 | $404.86 | $1308.18 |
| Long term debt | $1443.36 | $1375.4 | $1595.47 | $3052.98 |
| Total noncurrent liabilities | $1585.4 | $1698.59 | $1780.34 | $3236.41 |
| Total debt | $1498.84 | $1528.68 | $1637.41 | $3225.37 |
| Total liabilities | $2471.18 | $2175.17 | $2185.2 | $4544.59 |
| Shareholders' equity | ||||
| Retained earnings | $131.72 | $153.39 | -$119.75 | -$310.39 |
| Other shareholder equity | -$371.37 | |||
| Total shareholder equity | $2781.97 | $2812.73 | $2517.49 | $1899.46 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $815.63 | $796.04 | $768.05 | $742.8 |
| Cost of revenue | $507.57 | $501.73 | $484.27 | |
| Gross Profit | $288.47 | $266.32 | $258.53 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $109.69 | $101.07 | $98.11 | |
| Total operating expenses | $668.43 | $152.85 | $140.27 | $167.84 |
| Operating income | $135.62 | $126.06 | $90.69 | |
| Income from continuing operations | ||||
| EBIT | $133.28 | $123.67 | $98.41 | |
| Income tax expense | $27.2 | $25.64 | $20.07 | $20.21 |
| Interest expense | -$29.92 | $29.16 | $27.21 | $20.47 |
| Net income | ||||
| Net income | $68.13 | $78.48 | $76.38 | $57.73 |
| Income (for common shares) | $78.48 | $76.38 | $57.73 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2928.74 | $2610.4 | $2314.39 | $2089.93 |
| Cost of revenue | $1900.89 | $1697.11 | $1509.76 | $1399.61 |
| Gross Profit | $1027.85 | $913.29 | $804.63 | $690.32 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $388.91 | $349.28 | $301.34 | $262.27 |
| Total operating expenses | $980.83 | $469.39 | $427.23 | $341.18 |
| Operating income | $47.02 | $443.9 | $377.4 | $349.13 |
| Income from continuing operations | ||||
| EBIT | $50.76 | $437.01 | $335.19 | -$473.42 |
| Income tax expense | -$9.7 | $94.11 | $67.56 | $40.61 |
| Interest expense | $82.13 | $69.76 | $76.99 | $158.1 |
| Net income | ||||
| Net income | -$21.67 | $273.14 | $190.63 | -$672.13 |
| Income (for common shares) | -$21.67 | $273.14 | $190.63 | -$672.13 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $78.48 | $76.38 | $57.73 | |
| Operating activities | ||||
| Depreciation | $36.07 | $36.35 | $35.38 | |
| Business acquisitions & disposals | -$0.37 | -$50.35 | ||
| Stock-based compensation | $8.87 | $8.68 | $9.15 | |
| Total cash flows from operations | $171.15 | -$321.29 | $116.3 | |
| Investing activities | ||||
| Capital expenditures | -$153.09 | -$133.35 | -$109.93 | |
| Investments | ||||
| Total cash flows from investing | -$533.15 | -$155.48 | -$184.61 | -$110.17 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.66 | -$1.01 | $0.86 | |
| Net borrowings | -$15.36 | $483.24 | -$5.31 | |
| Total cash flows from financing | $502.23 | -$15.8 | $483.13 | -$5.65 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$17.93 | -$0.14 | -$22.77 | $0.48 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$21.67 | $273.14 | $190.63 | -$672.13 |
| Operating activities | ||||
| Depreciation | $132.35 | $117.77 | $106.72 | $95.26 |
| Business acquisitions & disposals | -$0.35 | -$9.51 | $1372.01 | |
| Stock-based compensation | $32.29 | $29.64 | $37.53 | $22.5 |
| Total cash flows from operations | $462.34 | $380.57 | $374.48 | $658.81 |
| Investing activities | ||||
| Capital expenditures | -$394.71 | -$289.07 | -$272.72 | -$216.52 |
| Investments | -$84.8 | |||
| Total cash flows from investing | -$397.22 | -$305.83 | $1017.63 | -$281.84 |
| Financing activities | ||||
| Dividends paid | -$0.92 | |||
| Sale and purchase of stock | -$44.34 | -$6.18 | ||
| Net borrowings | -$16.25 | -$113.59 | -$1648.87 | -$44.37 |
| Total cash flows from financing | -$62.7 | -$110.9 | -$1641.06 | -$51.5 |
| Effect of exchange rate | $4.07 | $4.09 | ||
| Change in cash and equivalents | $2.42 | -$36.16 | -$244.88 | $254.5 |
News
Fundamentals
| Market cap | $3.54B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 91.76M |
| Revenue | $3.12B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $280.73M |
| Revenue Q/Q | 8.70% |
| Revenue Y/Y | 9.13% |
| P/E ratio | 12.61 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.13 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $3.06 |
|---|---|
| ROA | 5.01% |
| ROE | N/A |
| Debt/Equity | 0.89 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.07 |
| Quick ratio | 1.06 |